Federation des caisses Desjardins du Quebec »

Nkgen Biotech shares owned by Federation des caisses Desjardins du Quebec

Quarter-by-quarter ownership of Nkgen Biotech (NKGN) shares owned by Federation des caisses Desjardins du Quebec from 13F filings

Historical chart of Federation des caisses Desjardins du Quebec investment in Nkgen Biotech

Tip: Access up to 7 years of quarterly data

All positions including Nkgen Biotech held by Federation des caisses Desjardins du Quebec consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nkgen Biotech by Federation des caisses Desjardins du Quebec

Quarter filed Position value Share count Share price at filing
2024-03-31 $945 500 1.89

More positions owned by Federation des caisses Desjardins du Quebec

Microsoft Corp Common Stock (MSFT)
Banque Toronto-dominion Common Stock (TD)
Royal Bank Cda Common Stock (RY)
Vanguard 500 Indx Etf- Exchange Traded Fund Share (VOO)
Banque De Nouvelle-ecosse Common Stock (BNS)
Brookfield Corp Cl-a Lvs Common Stock (BN)
Sun Life Financial Common Stock (SLF)
Apple Common Stock (AAPL)
Telus Corp Common Stock (TU)
Bank Of Montreal Common Stock (BMO)
Alphabet A Common Stock (GOOGL)
Amazon.com Common Stock (AMZN)
Nvidia Common Stock (NVDA)
Berkshire Hathaway-b- Common Stock (BRK.B)
Cdn Natl Railway Common Stock (CNI)

View all positions for Federation des caisses Desjardins du Quebec

Top funds holding Nkgen Biotech

Meteora Capital
Polar Securities
University Of Chicago
Vanguard Group
Geode Capital Management
Susquehanna International
Sequoia Financial Advisors
Northern Trust
UBS Group
Towneley Capital Management, Inc / DE
Tower Research Capital
Federation des caisses Desjardins du Quebec
Wells Fargo & Company

View all funds holding Nkgen Biotech